Published in J Natl Cancer Inst on October 01, 1986
Persisting risk of nickel related lung cancer and nasal cancer among Clydach refiners. Occup Environ Med (2006) 1.42
Mortality of workers at a nickel carbonyl refinery, 1958-2000. Occup Environ Med (2005) 1.33
New views on the hypothesis of respiratory cancer risk from soluble nickel exposure; and reconsideration of this risk's historical sources in nickel refineries. J Occup Med Toxicol (2009) 0.80
Cancer of the nose and paranasal sinuses in the metal industry: a case-control study. Br J Ind Med (1992) 0.78
Empirical evaluation of the influence of control selection schemes on relative risk estimation: the Welsh nickel workers study. Occup Environ Med (1995) 0.78
Cancer of the respiratory tract in nickel sinter plant workers: effect of removal from sinter plant exposure. Occup Environ Med (1994) 0.75
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J (1976) 28.28
The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst (1981) 25.60
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1998) 15.09
Observations on recent increase in mortality from asthma. Br Med J (1968) 14.82
A long-term follow-up study of women using different methods of contraception--an interim report. J Biosoc Sci (1976) 13.09
Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med (1991) 12.89
Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ (2000) 11.35
Investigation of relation between use of oral contraceptives and thromboembolic disease. Br Med J (1968) 9.17
Empirical Bayes estimates of age-standardized relative risks for use in disease mapping. Biometrics (1987) 8.67
Use of medicines in general practice. Br Med J (1977) 8.38
Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med (1997) 8.25
Mortality from smoking worldwide. Br Med Bull (1996) 7.87
Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health (1978) 7.80
Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet (2015) 7.29
Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer (1975) 7.20
Investigation into use of drugs preceding death from asthma. Br Med J (1968) 6.76
Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet (2008) 6.67
Cohort study analysis with a FORTRAN computer program. Int J Epidemiol (1986) 6.66
Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ (2004) 6.48
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Br Med J (1965) 5.67
Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J (1979) 5.58
The circumstances preceding death from asthma in young people in 1968 to 1969. Br J Dis Chest (1971) 5.53
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet (1998) 5.35
Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J (1980) 5.21
Frequency of eye complaints and rashes among patients receiving practolol and propranolol. Lancet (1977) 5.00
Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. BMJ (2005) 4.91
Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet (1995) 4.86
Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst (2004) 4.83
Mortality from lung cancer and other causes among workers in an asbestos textile factory. Br J Ind Med (1968) 4.81
The age distribution of cancer and a multi-stage theory of carcinogenesis. 1954. Int J Epidemiol (2004) 4.66
Mortality among doctors in different occupations. Br Med J (1977) 4.60
Structural barriers and facilitators in HIV prevention: a review of international research. AIDS (2000) 4.53
Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. Br Med J (1969) 4.50
Sudden fall in breast cancer death rates in England and Wales. Lancet (1995) 4.50
Can dietary beta-carotene materially reduce human cancer rates? Nature (1981) 4.43
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat Res (2007) 4.41
Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J (Clin Res Ed) (1985) 4.30
100 years of observation on British radiologists: mortality from cancer and other causes 1897-1997. Br J Radiol (2001) 4.25
Risk of lung cancer associated with residential radon exposure in south-west England: a case-control study. Br J Cancer (1998) 4.24
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer (2002) 4.18
Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet (1997) 4.16
Patient-to-patient transmission of HIV in private surgical consulting rooms. Lancet (1994) 4.12
Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri. Br J Cancer (1980) 4.11
Mortality of British doctors in relation to smoking: observations on coronary thrombosis. Natl Cancer Inst Monogr (1966) 3.92
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer (2008) 3.87
Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet (2001) 3.75
Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet (1995) 3.71
Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer (1987) 3.69
Immunosurveillance and cancer: epidemiological evidence. Br Med J (1970) 3.68
Mesothelioma mortality in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer (1982) 3.61
Treatment of gastric ulcer with carbenoxolone: antagonistic effect of spironolactone. Gut (1968) 3.46
Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol (2001) 3.35
What are the effects of the fifth revision of the Declaration of Helsinki? BMJ (2001) 3.17
A mathematical model for the age distribution of cancer in man. Int J Cancer (1969) 3.08
Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol (1986) 3.07
Trends in mortality among British doctors in relation to their smoking habits. J R Coll Physicians Lond (1972) 2.99
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet (1996) 2.97
The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer (2005) 2.81
Oral contraceptives and breast neoplasia: a retrospective study. Br Med J (1972) 2.81
Summarizing indices for comparison of cancer incidence data. Int J Cancer (1967) 2.80
Trends in mortality from cancer of the uterus in Canada and in England and Wales. Br J Prev Soc Med (1973) 2.80
Risk of lymphoedema following the treatment of breast cancer. Br J Surg (1986) 2.73
Prospects for prevention. Br Med J (Clin Res Ed) (1983) 2.68
Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C. Clin Infect Dis (2009) 2.68
Cancers of the lung and nasal sinuses in nickel workers. Br J Cancer (1970) 2.67
Immune response to Campylobacter pyloridis in patients with peptic ulceration. Lancet (1985) 2.64
Case-control study of the husbands of women with dysplasia or carcinoma of the cervix uteri. Lancet (1981) 2.63
Bladder cancer mortality in England and Wales in relation to cigarette smoking and saccharin consumption. Br J Prev Soc Med (1974) 2.60
Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet (1992) 2.60
Outcome of pregnancy in women using an intrauterine device. Lancet (1974) 2.58
Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet (1993) 2.58
A summary of mortality and incidence of cancer in men from the United Kingdom who participated in the United Kingdom's atmospheric nuclear weapon tests and experimental programmes. Br Med J (Clin Res Ed) (1988) 2.57
The geographical distribution of cancer. Br J Cancer (1969) 2.53
Geographical variation in mortality from leukaemia and other cancers in England and Wales in relation to proximity to nuclear installations, 1969-78. Br J Cancer (1989) 2.50
Minor tranquillisers and road accidents. Br Med J (1979) 2.50
Oral contraceptives and breast cancer. Progress report of an epidemiological study. Lancet (1975) 2.46
Mortality among patients with ankylosing spondylitis after a single treatment course with x rays. Br Med J (Clin Res Ed) (1982) 2.46
Mortality from cancer of the cervix uteri in British Columbia and other parts of Canada. Br J Prev Soc Med (1968) 2.44
Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol (1997) 2.40
A survey of doctors' attitudes to smoking. Br J Prev Soc Med (1969) 2.39
An epidemiological perspective of the biology of cancer. Cancer Res (1978) 2.39
Record linkage for drug monitoring. J Epidemiol Community Health (1981) 2.36
Trends in tar, nicotine, and carbon monoxide yields of UK cigarettes manufactured since 1934. Br Med J (Clin Res Ed) (1981) 2.35
Early oral contraceptive use and breast cancer: results of another case-control study. Br J Cancer (1987) 2.35
Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies. Lancet Oncol (2012) 2.33